Restylane Classyc Lidocaine
Galderma
This is the Restylane Classyc Lidocaine identity captured in the dated Aesthetic Pass operational catalogue snapshot. Product-specific source verification is available at family level only.
Evidence status: Catalogue identity · family sources available
The clinical research edition
Go deeper into the formulation and evidence
Explore composition, mechanism, safety and study interpretations for the exact presentation below. These new clinical drafts have a separate review process; this identity profile’s approval does not extend to them.
Identity record
What is recorded
- Record type
- Operational catalogue identity
- Recorded maker
- Galderma
- Classification
- Dermal filler
- Material identity
- Not recorded in this snapshot
- Snapshot date
- 14 August 2026
Manufacturer and category are catalogue fields. They are not, by themselves, a regulatory classification or verification of the exact marketed presentation.
Family evidence available
This identity maps to Restylane
The family profile provides aliases and official family-level sources. Those sources do not automatically verify this exact variant, formulation, label, or market status.
Open family profileProvenance
Family-level sources
These sources support the linked family profile, not every property of this exact catalogue identity.
- ManufacturerOpen source ↗
1. Restylane science and technology
Galderma · United States
Supports: Restylane family identity, named technologies, and hyaluronic-acid material class.
- RegulatorOpen source ↗
2. FDA-approved dermal fillers
U.S. Food and Drug Administration · United States
Supports: Regulatory-method context and the requirement to verify individual filler records and labels.
- RegulatorOpen source ↗
3. RESTYLANE injectable gel — PMA P040024
U.S. Food and Drug Administration · United States
Supports: The original US Restylane PMA record, Q-Med applicant identity, generic device class, and supplement history.
Use boundary
What this record does not establish
- Regulatory statusOnly within a source's named jurisdiction; family evidence does not establish status elsewhere.
- Authenticity or supply chainA catalogue name cannot authenticate an individual box, lot, or seller.
- Clinical suitabilityNo product selection, patient assessment, dose, protocol, or injection technique is provided.
- Availability or equivalenceNames, formulations, units, and presentations can vary by market and over time.
Separate reference from record-keeping
Document the exact product and lot actually used
Aesthetic Pass records treatment identity, lot information, photos, and injection maps. The atlas itself never chooses a product or treatment.